Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Samuel

Showing results (321-330 of 451) with videos related to

Pageof 46
Sort By:
AJR. American Journal of Roentgenology|April 21, 2021
Diffuse Versus Localized Caroli Disease: A Comparative MRCP StudyMaïté Lewin, Christophe Desterke, Catherine Guettier, et al.
Gastroenterology|March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized studyDidier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 14, 2020
Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation: A Pilot StudyDamien Dousse, Eric Vibert, Quentin Nicolas, et al.
Antiviral Therapy|August 28, 2015
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)Christophe Hézode, Laurent Alric, Ashley Brown, et al.
AIDS (London, England)|August 14, 2013
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graftTeresa M Antonini, Valerie Furlan, Elina Teicher, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 23, 2011
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation systemClaire Francoz, Jacques Belghiti, Denis Castaing, et al.
Journal of Hepatology|May 23, 2012
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirinYvon Calmus, Christophe Duvoux, Georges Pageaux, et al.
Transplantation|August 29, 2013
Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adultsMylène Sebagh, Marcela Castillo-Rama, Daniel Azoulay, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 18, 2019
Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysisNicolas Golse, Pablo Duarte, Andrea Fontana, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 12, 2019
Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathyVincent Algalarrondo, Teresa Antonini, Marie Théaudin, et al.
Pageof 46

Showing results (321-330 of 451) with videos related to

Sort By:
Pageof 46
AJR. American Journal of Roentgenology|April 21, 2021
Diffuse Versus Localized Caroli Disease: A Comparative MRCP StudyMaïté Lewin, Christophe Desterke, Catherine Guettier, et al.
Gastroenterology|March 4, 2003
Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized studyDidier Samuel, Thierry Bizollon, Cyrille Feray, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 14, 2020
Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation: A Pilot StudyDamien Dousse, Eric Vibert, Quentin Nicolas, et al.
Antiviral Therapy|August 28, 2015
Randomized controlled trial of the NS5A inhibitor daclatasvir plus pegylated interferon and ribavirin for HCV genotype-4 (COMMAND-4)Christophe Hézode, Laurent Alric, Ashley Brown, et al.
AIDS (London, England)|August 14, 2013
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graftTeresa M Antonini, Valerie Furlan, Elina Teicher, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 23, 2011
Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation systemClaire Francoz, Jacques Belghiti, Denis Castaing, et al.
Journal of Hepatology|May 23, 2012
Treatment of recurrent HCV infection following liver transplantation: results of a multicenter, randomized, versus placebo, trial of ribavirin alone as maintenance therapy after one year of PegIFNα-2a plus ribavirinYvon Calmus, Christophe Duvoux, Georges Pageaux, et al.
Transplantation|August 29, 2013
Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adultsMylène Sebagh, Marcela Castillo-Rama, Daniel Azoulay, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 18, 2019
Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysisNicolas Golse, Pablo Duarte, Andrea Fontana, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 12, 2019
Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathyVincent Algalarrondo, Teresa Antonini, Marie Théaudin, et al.
Pageof 46